.Observing a bad presenting for Lykos Therapeutics' MDMA candidate for trauma at a current FDA advis...
.AN2 Rehabs is reassessing its organization in reaction to dull midphase data, promising to give up ...
.Merck & Co. is actually paying $700 thousand ahead of time to challenge Amgen in a blood stream ...
.Along With Gilead Sciences about to an FDA choice for its liver health condition medicine seladelpa...
.CEO David Ricks can see the business establishing tents at basecamp responsible for Eli Lilly in an...
.Bed Liquidators has turned Entero Therapies white as a sheet. The collector got Entero to settle it...
.Exelixis is quiting on its tissue aspect (TF)- targeting antibody-drug conjugate after wrapping up ...
.Three weeks after Roche's Genentech device walked away from an SHP2 prevention contract, Relay Ther...
.Stoke Therapeutics' Dravet disorder drug has actually been devoid of a predisposed grip, getting ri...
.Tough Biotech Associate Publisher Gabrielle Masson showed the 2024 training class of Tough 15 champ...